Medication info
Rojetelpin Tablet 80/20/10/5 Milligrams

Rojetelpin Tablet 80/20/10/5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202202193 · Approved 2022.05.23 · Insurance code 643606410

Summary

Main use
Treatment of essential hypertension and dyslipidemia (including hypercholesterolemia)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of essential hypertension and dyslipidemia (including hypercholesterolemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients with both hypertension and dyslipidemia. It is particularly suitable for patients with essential hypertension who are taking a combination of telmisartan and amlodipine but are not achieving sufficient blood pressure control. Additionally, it helps effectively lower blood cholesterol and triglyceride levels and increase good cholesterol (HDL) in patients with dyslipidemia who are taking a combination of rosuvastatin and ezetimibe. This medication can be used when additional control is needed while taking multiple medications to improve both blood pressure and blood lipid levels together. Therefore, it is effectively used for combination treatment of hypertension and dyslipidemia.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. Muscle-related issues can present as severe muscle pain or weakness, which may lead to renal function problems; thus, if muscle pain occurs, consult a physician immediately. Patients with allergies to any of the components of this medication, or those with severely impaired liver or kidney function, should not take it. Patients with weakened liver or kidney function, hypothyroidism, and the elderly should exercise extra caution when taking this medication and undergo regular liver and kidney function tests. As this medication lowers blood pressure, hypotensive symptoms may occur, especially in patients with inadequate body fluids or salt, so caution is warranted. There is a risk of elevated potassium levels, so if potassium supplements or potassium-containing medications are taken concurrently, it must be done under a doctor's guidance. If symptoms such as muscle pain, weakness, fever, or similar arise, inform healthcare personnel immediately and undergo necessary tests. This medication can affect liver function; if symptoms of hepatitis or jaundice appear, stop taking it and consult a doctor. Be cautious of dizziness or drowsiness during driving or operating machinery. Interactions may occur if taken with other medications, so disclose all current medications to healthcare personnel. It is necessary to regularly check blood pressure, kidney function, liver function, and blood tests during the course of taking this medication.

Side effects

Eyelid damage, head injury, dysuria, flushing, chronic gastritis, various gastrointestinal disorders, hiatal hernia, facial swelling, unusual sensations, drug intolerance, chest pain, irritable bowel syndrome, colon polyps, esophagitis, dizziness, somnolence, neurodegenerative disorders, positional dizziness, migraine, diabetes, glucose tolerance impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, cold sweat, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum creatine kinase, reduced hemoglobin, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, dizziness, drowsiness, nausea, weakness, fatigue, pain, weight gain, loss, vasculitis, tension enhancement, sensory loss, peripheral neuropathy, taste abnormalities, tremors, extrapyramidal disorders, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, skin flush, papular rash, myocardial infarction, arrhythmia, blood pressure drop, sinus block, atrioventricular block, precordial pain, diarrhea, loose stools, constipation, heaviness, heat sensation, impaired glucose tolerance, weakness, angioedema, vascular edema, erythema multiforme, arthralgia, myalgia, elevation of creatine phosphokinase, myopathy, rhabdomyolysis, increased liver aminotransferase levels, hepatitis, cholelithiasis, cholecystitis, anaphylaxis, urticaria, rash, angioedema, hyperhidrosis, petechiae, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, amnesia, sleep disorders, nightmares, cognitive impairment, myasthenia gravis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature to preserve its effectiveness.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.